RT @Angiologist: TIL: Have you ever seen CHECKPOINT INHIBITOR associated digital ischemia? https://t.co/owN9WmFxuZ #oncology @SVM_tweets ht…
RT @Angiologist: TIL: Have you ever seen CHECKPOINT INHIBITOR associated digital ischemia? https://t.co/owN9WmFxuZ #oncology @SVM_tweets ht…
RT @Angiologist: TIL: Have you ever seen CHECKPOINT INHIBITOR associated digital ischemia? https://t.co/owN9WmFxuZ #oncology @SVM_tweets ht…
RT @Angiologist: TIL: Have you ever seen CHECKPOINT INHIBITOR associated digital ischemia? https://t.co/owN9WmFxuZ #oncology @SVM_tweets ht…
TIL: Have you ever seen CHECKPOINT INHIBITOR associated digital ischemia? https://t.co/owN9WmFxuZ #oncology @SVM_tweets https://t.co/D6PvJfvxX2
Paraneoplastic acral vascular syndrome in a patient with metastatic melanoma under immune checkpoint blockade. https://t.co/TJBbpUBQ58
Paraneoplastic acral vascular syndrome in a patient with metastatic melanoma under immune checkpoint blockade. https://t.co/75gR4K3LHx https://t.co/62OHu4fjge